Wai Conrad 4
4 · CLOVER HEALTH INVESTMENTS, CORP. /DE · Filed Jul 24, 2025
Insider Transaction Report
Form 4
Wai Conrad
CEO, Counterpart Health
Transactions
- Sale
Class A Common Stock
2025-07-22$3.29/sh−118,600$390,194→ 1,494,898 total(indirect: By Trust) - Sale
Class A Common Stock
2025-07-23$3.32/sh−91,197$302,774→ 1,403,701 total(indirect: By Trust)
Holdings
- 1,699,767
Class A Common Stock
Footnotes (3)
- [F1]The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 3, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.25 to $3.37, inclusive. The Reporting Person undertakes to provide to the SEC staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F2]Shares held in trust for the benefit of the Reporting Person's family, of which the Reporting Person is a co-trustee.
- [F3]The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 3, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.25 to $3.40, inclusive. The Reporting Person undertakes to provide to the SEC staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.